Table 2.
Parameters | Groups | |
---|---|---|
Control (n = 8) |
Treated (n = 8) |
|
Mortality | 0 | 0 |
Morbidity | 0 | 0 |
Alanine transaminase (U/L) | 83.3 ± 1.32 | 29.67 ± 0.333∗ |
Alkaline phosphatase (U/L) | 426 ± 49.7 | 333.0 ± 57.501 |
Bilirubin (mg/dl) | 0.438 ± 0.19 | 0.433 ± 0.066 |
Blood urea (mg/dl) | 40.3 ± 3.73 | 35.00 ± 3.152 |
Creatinine (mg/dl) | 0.64 ± 0.18 | 0.500 ± 0.0577 |
Serum uric acid (mg/dl) | 4.24 ± 0.73 | 2.533 ± 0.392 |
Data are presented as mean ± SEM. Data were analyzed using independent sample t-test. Asterisk (in row) shows significant difference with control group at p ≤ 0.05.